4.6 Article

CTR2 Identifies a Population of Cancer Cells with Stem Cell-like Features in Patients with Clear Cell Renal Cell Carcinoma

期刊

JOURNAL OF UROLOGY
卷 192, 期 6, 页码 1831-1841

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.juro.2014.06.070

关键词

kidney; carcinoma, renal cell; antigens, CD24; CTR2 protein, human; AC133 antigen

资金

  1. Italian Ministry of University and Research [MiUR-FIRB: RBAP11B2SX]

向作者/读者索取更多资源

Purpose: In clear cell renal cell carcinoma tissue samples we identified and characterized a population of renal cell carcinoma derived CD133+/CD24+ cancer cells. We studied differences between these cells and their nonneoplastic counterpart, tubular adult renal progenitor cells. Materials and Methods: CD133+/CD24+ renal cell carcinoma derived cells were isolated from 40 patients. The mesenchymal phenotype and stemness proteomic profile of these renal cell carcinoma derived cells were characterized. Colony forming efficiency and self-renewal ability were tested by limiting dilution. Tumorigenic properties were evaluated in vitro by soft agar assay. The angiogenic response was evaluated in vivo by the chorioallantoic membrane angiogenic assay. Microarray analysis was performed on 6 tubular adult renal progenitor cell and 6 renal cell carcinoma derived cell clones. Membrane protein expression was evaluated by flow cytometry and immunofluorescence staining. Results: CD133+/CD24+ cells were isolated from normal and tumor kidney tissue. Fluorescence activated cell sorting revealed that renal cell carcinoma derived cells did not express mesenchymal stem cell markers. CD133+/CD24+ tumor cells were more undifferentiated than tubular adult renal progenitor cells. Renal cell carcinoma derived cells were clonigenic and could differentiate into adipocytes, epithelial and osteogenic cells. They could also regenerate tumor cells in vitro and induce angiogenesis in vivo. Gene expression profile identified CTR2 as a membrane marker for this neoplastic population. CTR2 was involved in renal cell carcinoma derived cell cisplatin resistance. Conclusions: Our results indicate the presence of a CD133+/CD24+/CTR2+ cancer cell population in clear cell renal cell carcinoma. These cells have some stem cell-like features, including in vitro self-maintenance and differentiating capabilities, and they can induce an angiogenic response in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy

Savio Domenico Pandolfo, Davide Loizzo, Alp T. Beksac, Ithaar Derweesh, Antonio Celia, Lorenzo Bianchi, Jeffrey Elbich, Giovanni Costa, Umberto Carbonara, Giuseppe Lucarelli, Clara Cerrato, Margaret Meagher, Pasquale Ditonno, Lance J. Hampton, Giuseppe Basile, Fernando J. Kim, Riccardo Schiavina, Umberto Capitanio, Jihad Kaouk, Riccardo Autorino

Summary: This study compared the outcomes of robot-assisted partial nephrectomy (RAPN) and percutaneous thermal ablation (PTA) in the treatment of renal tumors cT1 in solitary kidney. The results showed that there were no significant differences in surgical, functional, and oncological outcomes between the two methods, but PTA may carry a higher risk of recurrence and may require retreatment.
Article Biochemistry & Molecular Biology

The cross-talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells

Sofia De Marco, Barbara Torsello, Emanuela Minutiello, Ivana Morabito, Chiara Grasselli, Silvia Bombelli, Nicola Zucchini, Giuseppe Lucarelli, Guido Strada, Roberto A. Perego, Cristina Bianchi

Summary: In this study, it was found that TGF-beta 1/Smad signaling is more activated in high-grade ccRCC and inversely correlated with Abl2 protein expression. TGF-beta 1 treatment increased the degradation of Abl2 protein and promoted tumor invasion and metastasis markers in ccRCC cells.

FEBS LETTERS (2023)

Review Biochemistry & Molecular Biology

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer

Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Matteo Ferro, Daniela Terracciano, Octavian Sabin Tataru, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli

Summary: Prostate cancer is a common malignancy in men and a leading cause of cancer death. The cancer cells have specific metabolic characteristics, including increased lipogenesis, cholesterogenesis, and reliance on glutamine. The tumor microenvironment also plays a role in cancer progression through interactions between cancer and stromal cells. The use of multi-omic approaches can provide a comprehensive understanding of the metabolic changes in prostate cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Urology & Nephrology

Percutaneous Ablation Vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up

Savio Domenico Pandolfo, Alp T. Beksac, Ithaar Derweesh, Antonio Celia, Riccardo Schiavina, Lorenzo Bianchi, Giovanni Costa, Umberto Carbonara, Davide Loizzo, Giuseppe Lucarelli, Clara Cerrato, Ciro Imbimbo, Vicenzo Mirone, Jeffrey Elbich, Giuseppe Basile, Lance J. Hampton, Fernando J. Kim, Umberto Capitanio, Jihad Kaouk, Riccardo Autorino

Summary: This study compared the outcomes of RAPN and PTA in treating completely endophytic renal masses. The results show that PTA treatment has low complications and good mid-term functional and oncologic outcomes. RAPN is more suitable for younger patients with fewer comorbidities.

JOURNAL OF ENDOUROLOGY (2023)

Article Chemistry, Multidisciplinary

Optimization of a Breath Analysis Methodology to Potentially Diagnose Transplanted Kidney Rejection: A Preclinic Study

Nicoletta De Vietro, Antonella Maria Aresta, Arcangelo Picciariello, Donato Francesco Altomare, Giuseppe Lucarelli, Alessia Di Gilio, Jolanda Palmisani, Gianluigi De Gennaro, Carlo Zambonin

Summary: Chronic kidney disease (CKD) can lead to end-stage renal disease and increased mortality. Kidney transplantation is the only definitive treatment, but organ rejection is a risk in the short-medium term. This preclinic study proposes the optimization of a non-invasive and cheap TD-GC-MS protocol to monitor CKD patients before and after surgery, with the aim of predicting kidney rejection. Using the ReCIVA((R)) device, the breath of healthy and pathological subjects was analyzed, identifying 67 molecules and quantifying 13 compounds with high prognostic values.

APPLIED SCIENCES-BASEL (2023)

Article Medicine, General & Internal

The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial

Biagio Barone, Benito Fabio Mirto, Alfonso Falcone, Francesco Del Giudice, Achille Aveta, Luigi Napolitano, Dario Del Biondo, Matteo Ferro, Gian Maria Busetto, Celeste Manfredi, Daniela Terracciano, Raffaele Gambardella, Savio Domenico Pandolfo, Francesco Trama, Ciro De Luca, Raffaele Martino, Federico Capone, Gaetano Giampaglia, Enrico Sicignano, Octavian Sabin Tataru, Giuseppe Lucarelli, Felice Crocetto

Summary: Bacterial prostatitis is a common prostatic infection that significantly affects quality of life. The combination of appropriate antibiotics and nutraceutical products can enhance treatment efficacy. This study found that the combination therapy of Flogofilm (R) and fluoroquinolones demonstrated significant improvement in pain, urinary symptoms, and quality of life in patients with chronic bacterial prostatitis, as indicated by IPSS and NIH-CPSI scores, compared to fluoroquinolones alone.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma

Francesco Lasorsa, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli

Summary: Globally, clear-cell renal cell carcinoma (ccRCC) is the most prevalent type of kidney cancer. Surgery is key in treatment, but a significant number of patients have metastatic ccRCC or experience recurrence. Molecular-target-based agents like TKIs and ICIs are recommended for advanced cancer treatment. The tumor microenvironment (TME) plays an essential role in cancer development and can be targeted for therapy. Understanding immune cell interactions with cancer and other TME elements is crucial for enhancing immunotherapies and reducing resistance.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma

Antonio Tufano, Costantino Leonardo, Chiara Di Bella, Giuseppe Lucarelli, Vincenzo Dolcetti, Piervito Dipinto, Flavia Proietti, Rocco Simone Flammia, Umberto Anceschi, Sisto Perdona, Giorgio Franco, Alessandro Sciarra, Giovanni Battista Di Pierro, Vito Cantisani

Summary: Contrast-enhanced ultrasound (CEUS) can differentiate clear cell renal cell carcinoma (ccRCC) from renal oncocytoma (RO). Heterogeneous enhancement and rim-like enhancement are independent predictors of ccRCC. These features can be clearly visualized on CEUS.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Urology & Nephrology

Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG

Roberto Contieri, Rodolfo Hurle, Marco Paciotti, Paolo Casale, Alberto Saita, Francesco Porpiglia, Cristian Fiori, Biagio Barone, Felice Crocetto, Giuseppe Lucarelli, Gian M. Busetto, Francesco Del Giudice, Martina Maggi, Francesco Cantiello, Rocco Damiano, Marco Borghesi, Pierluigi Bove, Riccardo Bertolo, Rocco Papalia, Andrea Mari, Stefano Luzzago, Francesco A. Mistretta, Francesco Soria, Paolo Gontero, Michele Marchioni, Evelina La Civita, Daniela Terracciano, Giorgio I. Russo, Luigi Schips, Sisto Perdona, Vincenzo Mirone, Octavian S. Tataru, Gennaro Musi, Mihai D. Vartolomei, Riccardo Autorino, Emanuele Montanari, Ottavio De Cobelli, Matteo Ferro

Summary: The European Association of Urology has updated the prognostic factor risk groups model for NMIBC and introduced a new group of patients at very high risk (VHR). They also proposed three additional clinical risk factors. However, the new scoring model was created without considering patients who received BCG intravesical therapy.

MINERVA UROLOGY AND NEPHROLOGY (2023)

Article Thermodynamics

3E (energy, economic, environmental) multi-objective optimization of CCHP industrial plant: Investigation of the optimal technology and the optimal operating strategy

Giuseppe Lucarelli, Matteo Genovese, Gaetano Florio, Petronilla Fragiacomo

Summary: The article discusses the use of a novel multi-objective optimization model for tri-generative energy systems, considering technical, economic, and environmental objectives. The model was employed to simulate the daily operation of various system configurations and evaluate the data. A comparison was made among 22 technology sets, resulting in the identification of an optimal tri-generation plant for a large industrial user.

ENERGY (2023)

Review Nutrition & Dietetics

Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS (R))

Felice Crocetto, Raffaele Balsamo, Ugo Amicuzi, Luigi De Luca, Alfonso Falcone, Benito Fabio Mirto, Gaetano Giampaglia, Gianpiero Ferretti, Federico Capone, Fabio Machiella, Domenico Varriale, Enrico Sicignano, Giovanni Pagano, Alessandro Lombardi, Giuseppe Lucarelli, Francesco Lasorsa, Gian Maria Busetto, Francesco Del Giudice, Matteo Ferro, Ciro Imbimbo, Biagio Barone

Summary: Urinary tract infections are a common and significant global health concern, with high recurrence rates and increasing antibiotic resistance. However, novel compounds such as D-mannose, chondroitin sulphate, hyaluronic acid, and N-acetylcysteine could provide important alternatives or adjuncts to existing prevention and treatment strategies. Numerous studies have evaluated the efficacy and potential use of these compounds in urinary tract health, particularly for urinary tract infections.

NUTRIENTS (2023)

Article Urology & Nephrology

Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients

Simona Simone, Francesco Pesce, Giulia Fonto, Virginia Pronzo, Paola Pontrelli, Francesca Conserva, Annalisa Schirinzi, Annalisa Casanova, Pasquale Gallo, Michele Rossini, Giuseppe Lucarelli, Marco Spilotros, Maria Rendina, Giovanni Stallone, Francesca Di Serio, Alfredo Di Leo, Silvio Tafuri, Pasquale Ditonno, Loreto Gesualdo

Summary: This study aimed to evaluate the seroconversion rate after BNT162b2 vaccine in kidney transplant recipients, factors associated with humoral response, and clinical outcome of COVID-19 in these patients. The results showed that after three doses of the vaccine, kidney transplant patients exhibited a late but effective immune response against SARS-CoV-2, reducing morbidity and mortality.

JOURNAL OF NEPHROLOGY (2023)

Meeting Abstract Urology & Nephrology

PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER STUDIES: RESULTS FROM A MACHINE LEARNING-BASED ANALYSIS OF A LARGE MULTI-INSTITUTIONAL DATABASE

Michele Marchioni, Annamaria Porreca, Marta Di Nicola, Giuseppe Lucarelli, Vartolomei Mihai Dorin, Francesco Soria, Daniela Tarracciano, Francesco Alessandro Mistretta, Carlo Buonerba, Francesco Cantiello, Andrea Mari, Andrea Minervini, Alessandro Veccia, Alessandro Antonelli, Gennaro Musi, Rodolfo Hurle, Gian Maria Busetto, Francesco Del Giudice, Benjamin I. Chung, Francesco Berardinelli, Sisto Perdona, Paola Del Prete, Vincenzo Mirone, Marco Borghesi, Angelo Porreca, Pierluigi Bove, Riccardo Autorino, Nicolae Crisan, Michele Battaglia, Pasquale Ditonno, Giorgio Ivan Russo, Matteo Muto, Rocco Damiano, Francesco Porpiglia, Ottavio De Cobelli, Luigi Schips, Matteo Ferro

JOURNAL OF UROLOGY (2023)

Meeting Abstract Urology & Nephrology

Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: Results from a machine learning-based analysis of a large multi-institutional database

M. Marchioni, A. Porreca, M. Di Nicola, G. Lucarelli, V. M. Dorin, F. Soria, D. Terracciano, F. A. Mistretta, C. Buonerba, F. Cantiello, A. Mari, A. Minervini, A. Veccia, A. Antonelli, G. Musi, R. Hurle, G. M. Busetto, F. Del Giudice, B. I. Chung, F. Berardinelli, S. Berdona, P. Del Prete, F. Porpiglia, L. Schips

EUROPEAN UROLOGY (2023)

Review Urology & Nephrology

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review

Matteo Ferro, Felice Crocetto, Biagio Barone, Francesco del Giudice, Martina Maggi, Giuseppe Lucarelli, Gian Maria Busetto, Riccardo Autorino, Michele Marchioni, Francesco Cantiello, Fabio Crocerossa, Stefano Luzzago, Mattia Piccinelli, Francesco Alessandro Mistretta, Marco Tozzi, Luigi Schips, Ugo Giovanni Falagario, Alessandro Veccia, Mihai Dorin Vartolomei, Gennaro Musi, Ottavio de Cobelli, Emanuele Montanari, Octavian Sabin Tataru

Summary: Radiomics and artificial intelligence (AI) have the potential to improve the differentiation and characterization of various renal lesions, including distinguishing benign from malignant lesions, differentiating different subtypes of renal cell carcinoma, and predicting clinical outcomes such as Fuhrman grade and treatment response. By analyzing imaging data using neural networks, quantitative features related to contour, heterogeneity, and gray zone can be extracted, providing valuable information for diagnosis and prognosis. Standardization of scanner protocols is crucial for enhancing the diagnostic ability of imaging tools and improving the accuracy in differentiating between benign and clinically significant renal cancers.

THERAPEUTIC ADVANCES IN UROLOGY (2023)

暂无数据